Written by the Nuvirox Research Team
- In aging mice, NAD+ precursors (NMN, NR) genuinely improve egg quality, ovulation and fertility — the animal data is striking.
- Human evidence is almost nonexistent: essentially no completed randomized trials, just a small retrospective signal and a great deal of extrapolation.
- Fertility is a high-stakes, individual medical area — this is a topic to navigate with a fertility specialist, not a supplement label.
Short answer: the mouse data is genuinely impressive, and the human data barely exists. NAD+ precursors clearly rejuvenate aging eggs in animals, which is why the topic generates so much excitement. But almost none of that has been demonstrated in women through proper trials — and given the stakes, this is one area where the gap between mouse and human really matters.
Why would NAD+ have anything to do with fertility?
Egg (oocyte) quality declines with age, and a major reason is energy. Eggs are exceptionally dependent on healthy mitochondria, and the process of maturing and being fertilized is metabolically demanding. NAD+ is central to mitochondrial energy production — and ovarian NAD+ levels fall with age, mirroring the decline seen elsewhere in the body [1].
The hypothesis follows naturally: if low NAD+ contributes to poor egg quality in aging, restoring NAD+ might help. It's a reasonable, mechanistically grounded idea — which is exactly why it deserves careful, honest evidence rather than hopeful marketing.
What the studies actually show
The animal evidence is genuinely strong. In a landmark 2020 study, supplementing aged mice with an NAD+ precursor restored oocyte quality, improved ovulation, and enhanced fertility outcomes [1]. A separate 2020 study found that NMN supplementation reversed the declining quality of maternally aged mouse oocytes, improving their ability to be fertilized and develop [2]. These are well-conducted studies with consistent, biologically plausible results.
The honest counterweight: human evidence is almost absent. A 2025 systematic review of NMN and oocyte quality found that the high-quality evidence remains preclinical — animal studies and lab work, not completed randomized human trials. The strongest human-adjacent signal is a small retrospective analysis suggesting NMN pretreatment might improve ovarian response in young women with diminished ovarian reserve — but a retrospective abstract is a hypothesis-generator, not proof. We simply do not yet have the randomized human trials that would tell us whether this works, at what dose, or safely, in women trying to conceive.
This is the crux. The mouse data is the kind that should motivate proper human trials — and those trials are starting — but it is not the kind that should motivate a confident purchase decision today. The distance between "works in aged mice" and "helps a woman conceive" is exactly where many promising interventions have failed.
Why caution matters more here than usual
Most NAD+ topics are low-stakes — if a supplement doesn't do much for your afternoon energy, you've lost some money. Fertility is different. Decisions are time-sensitive, emotionally weighted, and medically complex, and the window people are working within can be narrow. Relying on an unproven supplement in place of timely, evidence-based fertility care carries a real opportunity cost. Safety during attempts to conceive and in early pregnancy is also not well characterized for these precursors, which is another reason to involve a clinician.
What NAD+ won't do
It won't reverse age-related fertility decline on the strength of current human evidence — that claim isn't supported. It isn't a substitute for fertility evaluation or treatment, and it shouldn't delay seeing a specialist if you're trying to conceive and concerned. If fertility is your goal, the highest-value step is a conversation with a fertility doctor who can assess your specific situation — the animal research is interesting context for that conversation, not a reason to bypass it.
Frequently asked questions
Does NMN or NAD+ improve egg quality in women?
In aging mice, NAD+ precursors clearly improve egg quality and fertility. In women, the evidence is almost nonexistent — a 2025 systematic review found the strong data is still preclinical. It's a promising research direction, not a proven intervention.
Should I take NMN if I'm trying to conceive?
This is a question for a fertility specialist, not a supplement label. Human safety and efficacy during conception attempts aren't well established, and relying on an unproven supplement could cost valuable time. Get individualized medical guidance first.
Why does fertility decline with age in the first place?
Egg quality and quantity fall with age, driven substantially by mitochondrial and energy-related changes — which is where the NAD+ hypothesis comes from. But many factors contribute, and the picture is individual. A specialist can assess yours.
Is the mouse data meaningless then?
Not at all — it's genuinely strong and is driving human research now. But mouse fertility results have a long history of not translating directly to humans, so it should motivate proper trials, not purchases.
Why we formulated NAD+ Restore
On fertility specifically, we won't make claims the human evidence doesn't support — and we'd point anyone focused on conceiving toward a fertility specialist first. If your situation involves a specific medical concern, that's a conversation to have with a clinician first — a supplement isn't a treatment, and this is one area where individual guidance matters.
For general cellular-health support, NAD+ Restore provides 500 mg of nicotinamide riboside chloride (NR), one of the two most-researched NAD+ precursors, within the dose range used in published human trials. It adds 150 mg trans-resveratrol and 50 mg quercetin — polyphenols studied alongside NAD+ pathways — plus 10 mg galactomannans from fenugreek to support absorption.
It's backed by a 60-day money-back guarantee.
Learn more about NAD+ Restore →The trials that would actually answer this
It's worth being concrete about what would move fertility from 'promising in mice' to 'useful in humans,' because that's the evidence to watch for. We'd want randomized controlled trials in women — ideally those of advanced maternal age or with diminished ovarian reserve — comparing an NAD+ precursor against placebo, measuring real outcomes like egg quality, fertilization rates, embryo development, and ultimately pregnancies and live births. We'd want clear safety data for the conception window and early pregnancy. And we'd want enough participants and rigor that a positive result couldn't be a fluke.
Some early-stage human research is beginning, which is genuinely encouraging. But until those trials report, anyone selling NAD+ precursors as a fertility intervention is getting ahead of the evidence in an area where the cost of being wrong — lost time, false hope, money diverted from proven care — is unusually high. That's why a fertility specialist, not a supplement label, should guide these decisions.
The bottom line
NAD+ and fertility is a case where the animal science is genuinely exciting and the human science barely exists. NAD+ precursors rejuvenate aging eggs in mice; whether they help women conceive is unproven, and the stakes make that gap matter. Treat the mouse data as a reason for researchers to run trials — not as a reason to self-treat. If fertility is your concern, a specialist is the right next step. For the underlying biology, our piece on whether NAD+ declines with age covers the decline this hypothesis is built on, and NAD+ and anti-aging covers the broader longevity claims this borrows from.
References
- Bertoldo MJ, Listijono DR, Ho WJ, et al. NAD+ repletion rescues female fertility during reproductive aging. Cell Rep. 2020;30(6):1670-1681.e7. doi:10.1016/j.celrep.2020.01.058. PMID: 32049000.
- Miao Y, Cui Z, Gao Q, et al. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep. 2020;32(5):107987. doi:10.1016/j.celrep.2020.107987. PMID: 32755581.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x. PMID: 33353981.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.